Seki, R <br/><br/>
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2010 
 - 833-841 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdp481  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Biomarkers, Tumor--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p27--metabolism<br/>Cyclophosphamide<br/>Doxorubicin<br/>Female<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--diagnosis<br/>Male<br/>Middle Aged<br/>Prednisone<br/>Prognosis<br/>Retrospective Studies<br/>Rituximab<br/>S-Phase Kinase-Associated Proteins--metabolism<br/>Survival Analysis<br/>Vincristine<br/>Young Adult